Using calreticulin exposed on the surface of tumor cells, which operates as an “eat me” signal to stimulate uptake of tumor antigens by APCs, we showed that the combination treatment increased this hallmark of immunogenic cell death (Figure 6D). This evidence concerns the gene CALR and neoplasm.